20 studies found for:    glioblastoma multiforme pediatrics
Show Display Options
Rank Status Study
1 Recruiting Dendritic Cell Vaccine For Malignant Glioma and Glioblastoma Multiforme in Adult and Pediatric Subjects
Conditions: Malignant Glioma;   Glioblastoma Multiforme;   Anaplastic Astrocytoma;   High Grade Glioma
Interventions: Biological: Dendritic Cell Vaccine;   Biological: Tumor Lysate;   Other: Imiquimod;   Procedure: Leukapheresis
2 Recruiting Dendritic Cell Vaccine Therapy With In Situ Maturation in Pediatric Brain Tumors
Conditions: Glioma;   Brain Cancer;   Brain Tumor;   Glioblastoma Multiforme;   High Grade Glioma
Interventions: Biological: Dendritic Cell Vaccine;   Biological: Tumor Lysate;   Other: Imiquimod;   Procedure: Punch Biopsy of the Skin;   Procedure: Leukapheresis
3 Withdrawn Valproic Acid in Childhood Progressive Brain Tumors
Conditions: Pediatric Brain Tumor;   Glioma;   Anaplastic Astrocytoma;   Medulloblastoma;   Glioblastoma
Intervention: Drug: Valproic Acid
4 Recruiting A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors
Conditions: Malignant Glioma;   Recurrent Ependymoma
Interventions: Biological: AdV-tk;   Drug: valacyclovir;   Radiation: Radiation
5 Recruiting p28 in Treating Younger Patients With Recurrent or Progressive Central Nervous System Tumors
Conditions: Childhood Atypical Teratoid/Rhabdoid Tumor;   Childhood Choroid Plexus Tumor;   Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor
Interventions: Drug: azurin-derived cell-penetrating peptide p28;   Other: laboratory biomarker analysis;   Other: pharmacological study
6 Recruiting Evaluation of FDOPA-PET/MRI in Pediatric Patients With CNS Tumors
Conditions: Astrocytoma, Oligoastrocytoma, Mixed;   Ganglioneuroma;   Glioma;   Ganglioglioma;   Glioblastoma Multiforme Glioma
Interventions: Drug: Irinotecan;   Drug: Bevacizumab;   Device: FDOPA-PET/MRI imaging
7 Unknown  A Phase I/II Study of the Photon Radiosurgery System
Conditions: Brain Tumor, Recurrent;   Glioblastoma Multiforme
Intervention: Procedure: Photon Radiosurgery System (Intrabeam)
8 Completed
Has Results
Lapatinib in Treating Young Patients With Recurrent or Refractory Central Nervous System Tumors
Conditions: Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Brain Stem Glioma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Medulloblastoma;   Recurrent Childhood Oligodendroglioma
Interventions: Drug: lapatinib ditosylate;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis;   Other: pharmacological study;   Procedure: positron emission tomography;   Procedure: magnetic resonance imaging
9 Completed
Has Results
Gefitinib and Radiation Therapy in Treating Children With Newly Diagnosed Gliomas
Conditions: Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Anaplastic Oligodendroglioma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliomatosis Cerebri;   Untreated Childhood Gliosarcoma;   Untreated Childhood Oligodendroglioma
Interventions: Drug: gefitinib;   Radiation: radiation therapy;   Other: pharmacological study;   Other: laboratory biomarker analysis
10 Recruiting Photodynamic Therapy (PDT) for Brain Tumors
Condition: Brain Tumor, Recurrent
Intervention: Drug: Photofrin (porfimer sodium) & photodynamic therapy.
11 Recruiting Imetelstat Sodium in Treating Younger Patients With Recurrent or Refractory Brain Tumors
Conditions: Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Ependymoma;   Recurrent Childhood Diffuse Astrocytoma;   Recurrent Childhood Ependymoma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliosarcoma;   Recurrent Childhood Oligodendroglioma;   Recurrent Childhood Brain Stem Glioma
Interventions: Drug: imetelstat sodium;   Other: laboratory biomarker analysis;   Other: pharmacological study
12 Unknown  Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS Tumors
Conditions: Bone Marrow Suppression;   Brain and Central Nervous System Tumors;   Drug/Agent Toxicity by Tissue/Organ
Interventions: Procedure: filgrastim;   Biological: gene therapy;   Drug: lomustine;   Drug: procarbazine hydrochloride;   Drug: vincristine sulfate;   Procedure: in vitro-treated peripheral blood stem cell transplantation
13 Recruiting Oncolytic HSV-1716 in Treating Younger Patients With Refractory or Recurrent High Grade Glioma That Can Be Removed By Surgery
Conditions: Recurrent Childhood Anaplastic Astrocytoma;   Recurrent Childhood Anaplastic Oligoastrocytoma;   Recurrent Childhood Anaplastic Oligodendroglioma;   Recurrent Childhood Giant Cell Glioblastoma;   Recurrent Childhood Glioblastoma;   Recurrent Childhood Gliomatosis Cerebri;   Recurrent Childhood Gliosarcoma
Interventions: Biological: oncolytic HSV-1716;   Drug: dexamethasone;   Procedure: therapeutic conventional surgery;   Other: laboratory biomarker analysis
14 Completed Chemotherapy and Radiation Therapy After Surgery in Treating Children With Newly Diagnosed Astrocytoma, Glioblastoma Multiforme, Gliosarcoma, or Diffuse Intrinsic Pontine Glioma
Condition: Brain and Central Nervous System Tumors
Interventions: Drug: temozolomide;   Procedure: adjuvant therapy;   Radiation: radiation therapy
15 Withdrawn A Pilot Study Evaluating 18F-L-Thymidine (FLT) PET Imaging in Children With Gliomas
Conditions: Ependymoma;   Brainstem Glioma;   Astrocytoma;   Glioblastoma Multiforme;   PNET
Intervention:
16 Completed Erlotinib and Temozolomide With Radiation Therapy in Treating Patients With Glioblastoma Multiforme or Other Brain Tumors
Conditions: Adult Giant Cell Glioblastoma;   Adult Glioblastoma;   Adult Gliosarcoma
Interventions: Drug: erlotinib hydrochloride;   Radiation: 3-dimensional conformal radiation therapy;   Drug: temozolomide
17 Terminated Cilengitide and Metronomic Temozolomide for Relapsed or Refractory High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas in Children and Adolescents
Condition: Gliomas
Interventions: Drug: Cilengitide;   Drug: Temozolomide
18 Recruiting Veliparib, Radiation Therapy, and Temozolomide in Treating Younger Patients With Newly Diagnosed Diffuse Pontine Gliomas
Conditions: Childhood Mixed Glioma;   Untreated Childhood Anaplastic Astrocytoma;   Untreated Childhood Brain Stem Glioma;   Untreated Childhood Fibrillary Astrocytoma;   Untreated Childhood Giant Cell Glioblastoma;   Untreated Childhood Glioblastoma;   Untreated Childhood Gliosarcoma
Interventions: Drug: veliparib;   Drug: temozolomide;   Radiation: 3-dimensional conformal radiation therapy;   Radiation: intensity-modulated radiation therapy;   Other: pharmacological study;   Other: laboratory biomarker analysis
19 Unknown  Safety Study of Seneca Valley Virus in Patients With Solid Tumors With Neuroendocrine Features
Conditions: Carcinoid;   Neuroendocrine
Intervention: Drug: Seneca Valley Virus (biological agent)
20 Unknown  Study of Busulfan for Refractory Central Nervous System (CNS) Tumors
Condition: Refractory Brain Tumors
Intervention: Drug: Busulfan

Indicates status has not been verified in more than two years